macrolide antibiotics known effective treatment chronic inflammatory airway diseases including diffuse panbronchiolitis chronic bronchitis bronchial asthma having antimicrobial activities macrolides antiinflammatory effects inhibition cytokine production present study investigated effects clarithromycin cam interleukin gene expression protein levels using human bronchial epithelial cell line northern blot analyses showed cam inhibited tumor necrosis factor gene expression incubation manner messenger rna transcripts cells did change cam transfection studies cells using fusion genes composed sequences gene luciferase reporter gene demonstrated potent promoter activity segment NUMBER bp relative transcription start site segment includes activator protein nuclear factor sites exhibited strongest response promoter activity segment showed significant repression cam segment NUMBER bp does include site includes site did significant repression promoter activity cam mutation binding site abrogated suppression cam tnfalphainduced enhancement luciferase activity accord promoter analyses electrophoretic mobility shift assay showed cam repressed binding bet1a cells induced binding activities bet1a cells data suggest macrolides cam repress il8 gene transcription mainly binding site human bronchial epithelial cells findings provide novel mechanism antiinflammatory function macrolides implicating target development new drugs treating chronic airway inflammation il NUMBER bet 1a tnf alpha induced dose time dependent half life il NUMBER tnf alpha treated bet 1a NUMBER flanking il NUMBER NUMBER bp NUMBER ap NUMBER nf kappab like tnf alpha NUMBER bp NUMBER ap NUMBER nf kappab like tnf alpha induced ap NUMBER tnf alpha induced ap NUMBER tnf alpha treated tnf alpha ap NUMBER nf kappab bet 1a il NUMBER ap NUMBER